de-DEen-US
Zum Inhalt springen
Ressourcen zur psychedelischen Forschung und Bewusstseinserweiterung (LSD Derivate)

Wissenschaftliche Forschung

Bedeutung und Potenzial von Psychedelika in der Wissenschaft

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S.E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., Schmidt, B.L. (2016) Journal of Psychopharmacology , 30(12) , 1165-1180

Zusammenfassung

Double-blind, placebo-controlled, crossover trial with 29 cancer patients with anxiety and depression. Single-dose psilocybin produced immediate, substantial, and sustained improvements in anxiety and depression, with approximately 60-80% maintaining clinically significant reductions at follow-up.

Schlüsselwörter

psilocybincanceranxietydepressionpalliative careNYU
Klinische Forschung
Artikel ansehen